Document is current
Any future updates will be listed below
-
Authors
Jeong, Han Saem
Hong, Soon Jun
Son, Serhim
An, Hyonggin
Kook, Hyungdon
Joo, Hyung Joon
Park, Jae Hyoung
Yu, Cheol Woong
Lim, Do-Sun
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02545231 at ClinicalTrials.govDocuments that mention this clinical trial
Effects of lowest-dose vs. highest-dose pitavastatin on coronary neointimal hyperplasia at 12-month follow-up in type 2 diabetic patients with non-ST elevation acute coronary syndrome: an optical coherence tomography analysis
https://doi.org/10.1007/s00380-018-1227-0
Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up
https://doi.org/10.1186/s12933-019-0969-z
-
Funding
Funding for this research was provided by:
National Research Foundation (NRF-2018M3A9A8017949)
- License Information
-
More Information
Article History
Received: 16 September 2019
Accepted: 13 November 2019
First Online: 21 November 2019
Ethics approval and consent to participate
: All patients provided written informed consent. The study was approved by the Korea University Hospital Institutional Review Board.
: Not applicable.
: The authors declare that they have no competing interests.
